Filing Details
- Accession Number:
- 0001415889-24-004452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 18:14:48
- Reporting Period:
- 2024-02-15
- Accepted Time:
- 2024-02-20 18:14:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1845337 | Day One Biopharmaceuticals Inc. | DAWN | Pharmaceutical Preparations (2834) | 832415215 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1863107 | Jeremy Bender | 2000 Sierra Point Parkway, Suite 501 Brisbane CA 94005 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-15 | 3,562 | $0.00 | 712,991 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-15 | 4,750 | $0.00 | 717,741 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-15 | 11,687 | $0.00 | 729,428 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-16 | 7,615 | $15.25 | 721,813 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-02-15 | 3,562 | $0.00 | 3,562 | $0.00 |
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-02-15 | 4,750 | $0.00 | 4,750 | $0.00 |
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-02-15 | 11,687 | $0.00 | 11,687 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,942 | No | 4 | M | Direct | ||
| 52,250 | No | 4 | M | Direct | ||
| 175,313 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 221,837 | Indirect | See footnote |
| Common Stock | 300,025 | Indirect | See footnote |
| Common Stock | 251,636 | Indirect | See footnote |
| Common Stock | 270,226 | Indirect | See footnote |
Footnotes
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
- Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person is trustee.
- Represents shares held by The Jeremy Bender 2023 Grantor Retained Annuity Trust dated June 27, 2023.
- Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022of which the Reporting Person's spouse is trustee.
- Represents shares held by The Melissa Bender 2023 Grantor Retained Annuity Trust, dated June 27, 2023.
- The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Billionaire Hedge Funds
